BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 25326175)

  • 1. Recent developments in therapeutic protein expression technologies in plants.
    Fahad S; Khan FA; Pandupuspitasari NS; Ahmed MM; Liao YC; Waheed MT; Sameeullah M; Darkhshan ; Hussain S; Saud S; Hassan S; Jan A; Jan MT; Wu C; Chun MX; Huang J
    Biotechnol Lett; 2015 Feb; 37(2):265-79. PubMed ID: 25326175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards molecular farming in the future: moving from diagnostic protein and antibody production in microbes to plants.
    Fischer R; Drossard J; Commandeur U; Schillberg S; Emans N
    Biotechnol Appl Biochem; 1999 Oct; 30(2):101-8. PubMed ID: 10512787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-produced biopharmaceuticals: A case of technical developments driving clinical deployment.
    Lomonossoff GP; D'Aoust MA
    Science; 2016 Sep; 353(6305):1237-40. PubMed ID: 27634524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody production by molecular farming in plants.
    Fischer R; Hoffmann K; Schillberg S; Emans N
    J Biol Regul Homeost Agents; 2000; 14(2):83-92. PubMed ID: 10841283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular farming of recombinant antibodies in plants.
    Fischer R; Liao YC; Hoffmann K; Schillberg S; Emans N
    Biol Chem; 1999; 380(7-8):825-39. PubMed ID: 10494831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview.
    Floss DM; Falkenburg D; Conrad U
    Transgenic Res; 2007 Jun; 16(3):315-32. PubMed ID: 17436059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soybeans as bioreactors for biopharmaceuticals and industrial proteins.
    Vianna GR; Cunha NB; Murad AM; Rech EL
    Genet Mol Res; 2011; 10(3):1733-52. PubMed ID: 21863568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of antibodies in plants and their use for global health.
    Fischer R; Twyman RM; Schillberg S
    Vaccine; 2003 Jan; 21(7-8):820-5. PubMed ID: 12531368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plantibodies: applications, advantages and bottlenecks.
    Stoger E; Sack M; Fischer R; Christou P
    Curr Opin Biotechnol; 2002 Apr; 13(2):161-6. PubMed ID: 11950570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developments in the production of mucosal antibodies in plants.
    Vasilev N; Smales CM; Schillberg S; Fischer R; Schiermeyer A
    Biotechnol Adv; 2016; 34(2):77-87. PubMed ID: 26626615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plant-made vaccine antigens and biopharmaceuticals.
    Daniell H; Singh ND; Mason H; Streatfield SJ
    Trends Plant Sci; 2009 Dec; 14(12):669-79. PubMed ID: 19836291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plants as bioreactors for the production of vaccine antigens.
    Tiwari S; Verma PC; Singh PK; Tuli R
    Biotechnol Adv; 2009; 27(4):449-67. PubMed ID: 19356740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-made vaccines and reagents for the One Health initiative.
    Rybicki EP
    Hum Vaccin Immunother; 2017 Dec; 13(12):2912-2917. PubMed ID: 28846485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein production in moss bioreactors.
    Decker EL; Reski R
    Plant Cell Rep; 2012 Mar; 31(3):453-60. PubMed ID: 21960098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant bioreactors for pharmaceuticals.
    Miao Y; Ding Y; Sun QY; Xu ZF; Jiang L
    Biotechnol Genet Eng Rev; 2008; 25():363-80. PubMed ID: 21412362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and risks of antibody and vaccine production in transgenic plants.
    Warzecha H; Mason HS
    J Plant Physiol; 2003 Jul; 160(7):755-64. PubMed ID: 12940544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moss bioreactors producing improved biopharmaceuticals.
    Decker EL; Reski R
    Curr Opin Biotechnol; 2007 Oct; 18(5):393-8. PubMed ID: 17869503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of biopharmaceuticals and vaccines in plants via the chloroplast genome.
    Daniell H
    Biotechnol J; 2006 Oct; 1(10):1071-9. PubMed ID: 17004305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant virus expression vector development: new perspectives.
    Hefferon K
    Biomed Res Int; 2014; 2014():785382. PubMed ID: 24745025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-based pharmaceutical production in plants: an opportunity to reduce health problems in Africa.
    Bamogo PKA; Brugidou C; Sérémé D; Tiendrébéogo F; Djigma FW; Simpore J; Lacombe S
    Virol J; 2019 Dec; 16(1):167. PubMed ID: 31888686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.